SAFETY OF ANTIMALARIALS IN THE FIRST TRIMESTER: AN ADAPTIVE PLATFORM TRIAL

Project Information

SAFIRE

Grant agreement ID: 101145740

DOI

10.3030/101145740

EC signature date 11 March 2024

Start date 1 June 2024

End date 30 November 2028

Funded under

• Health

Total cost

€ 5 191 431,44

EU contribution

€ 5 191 431,44

Coordinated by

STICHTING AMSTERDAM UMC
Netherlands

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Deliverables

Websites, patent fillings, videos etc. (1)

Project webpage

A website with a project overview and consortium

Publications

Peer reviewed articles (1)

Development of Context-Appropriate Recruitment and Retention Approaches for Pregnant Women in the SAFIRE Clinical Trial Assessing Safety and Efficacy of Artemisinin-Combination Therapies: A Formative Research Protocol

Author(s): Jenna Hoyt, Adélaïde Compaoré, Samba Diarra, Freddy Bikioli Bolombo, Susan Nayiga, Serge Henri Zango, Moussa Djimde, Stephanie Dellicour, Japhet Kabalu Tshiongo, Hypolite Muhindo-Mavoko, Abel Kakuru, Simon Kariuki, Hellen Barsosio, Kassoum Kayentao, Innocent Valea, Jenny Hill, Maud Majeres Lugand
Published in: International Journal of Qualitative Methods, Issue 25, 2026, ISSN 1609-4069
Publisher: SAGE Publications
DOI: 10.1177/16094069261449007